The American Cancer Society received a $9.1 million grant from the Lisa Dean Moseley Foundation to establish the American Cancer Society Lisa Dean Moseley Foundation Cancer Stem Cell Consortium, the organization said Jan. 19.
The new project will be a six-year initiative supporting the peer-reviewed work of up to 15 researchers aiming to accelerate cancer stem cell research. A nationally recognized cancer researcher with an expertise in cancer stem cells will be selected to lead the consortium. A request for project applications will be released this month.
"The Consortium will bring together investigators from institutions across the US working on shared, focused research questions to advance the understanding of cancer stem cells and to leverage this knowledge to design and test strategies to prevent cancer stem cells from contributing to metastasis, treatment resistance, and disease recurrence," said Lynne Elmore, MD, American Cancer Society senior scientific director of the consortium.
"Importantly, this program is designed to provide unique opportunities for early-career researchers, who will be mentored by more established scientists, as well as to strengthen and grow the cancer stem cell research field."